Southwest Journal of Pulmonary and Critical Care (Feb 2018)

Tacrolimus-associated diabetic ketoacidosis: a case report and literature review

  • Pak S ,
  • Hirschbeck M ,
  • Valencia D ,
  • Valencia V ,
  • Askaroglu Y ,
  • Nye D ,
  • Fershko A

DOI
https://doi.org/10.13175/swjpcc015-18
Journal volume & issue
Vol. 16, no. 2
pp. 103 – 107

Abstract

Read online

Post-transplant diabetes mellitus is a well-established adverse effect of calcineurin inhibitors, such as tacrolimus and cyclosporine. Failure to identify and manage this side effect in a timely manner could lead to life-threatening complications like diabetic ketoacidosis (DKA). To the best of our knowledge, this is the seventh published case of an uncommon but severe, and potentially fatal, adverse effect from tacrolimus after renal transplantation. The purpose of this case report is to add to the scant body of literature on tacrolimus-induced diabetes following renal transplantation.

Keywords